How does Leuprolide work in the treatment of prostate cancer, and what mechanisms underlie its ability to reduce testosterone levels and slow disease progression?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Leuprolide, a GnRH agonist, inhibits testosterone production by initially stimulating, then desensitizing pituitary gland receptors, reducing LH and FSH release, thus slowing prostate cancer growth.
Leuprolide, a GnRH agonist, reduces testosterone by inhibiting luteinizing hormone release, slowing prostate cancer progression by starving tumor cells of needed androgens.